CD4 and psoriasis: EZH2 was previously shown to relate to keratinocyte proliferation and inflammatory responses in psoriasis [15,76], and it may also affect CD4+ and CD8+ T cell differentiation [121,122] and epidermal stratification [123,124], potentially contributing to psoriatic hyperkeratosis [125,126].